Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-man Safety and Performance of OSTEO3 ZP PUTTY in Subjects Undergoing Transforaminal Lumbar Interbody Fusion

NCT05114135 is registered in ClinicalTrials.gov with OssDsign as lead sponsor.

NCT NCT05114135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05114135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-man Safety and Performance of OSTEO3 ZP PUTTY in Subjects Undergoing Transforaminal Lumbar Interbody Fusion
Lead sponsor
OssDsign
Phase
Not applicable
Overall status
Completed
Start date
September 7, 2021
Completion date
March 14, 2024
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, degenerative spondylolisthesis, lumbar spinal stenosis